268 related articles for article (PubMed ID: 34691324)
1. Clinical Characteristics and Outcomes in Immune Checkpoint Inhibitor Therapy-Associated Myocarditis.
Thakker RA; Lee MA; Albaeni A; Elbadawi A; Suthar KH; Perez C; Sonstein LK; Farr NM; Venkatesan R; Khalife W; Berbarie RF; Chatila KF
Cardiol Res; 2021 Oct; 12(5):270-278. PubMed ID: 34691324
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy.
Balanescu DV; Donisan T; Palaskas N; Lopez-Mattei J; Kim PY; Buja LM; McNamara DM; Kobashigawa JA; Durand JB; Iliescu CA
Cardiovasc Pathol; 2020; 47():107211. PubMed ID: 32268262
[TBL] [Abstract][Full Text] [Related]
3. Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series.
Zhang RS; Padegimas A; Murphy KM; Evans PT; Peters CJ; Domenico CM; Vidula MK; Mather PJ; Cevasco M; Cohen RB; Carver JR; O'Quinn RP
Cardiooncology; 2021 Mar; 7(1):13. PubMed ID: 33785062
[TBL] [Abstract][Full Text] [Related]
4. Immune Checkpoint Inhibitor-Related Myocarditis: Recognition, Surveillance, and Management.
Kuhnly NM; Coviello J
Clin J Oncol Nurs; 2022 Feb; 26(1):54-60. PubMed ID: 35073300
[TBL] [Abstract][Full Text] [Related]
5. Immune Checkpoint Inhibitor-Associated Myocarditis: A Literature Review.
Gul R; Shehryar M; Mahboob A; Kareem HK; Inayat A; Safi D; Kamran A
Cureus; 2024 Jan; 16(1):e52952. PubMed ID: 38406102
[TBL] [Abstract][Full Text] [Related]
6. Immune Checkpoint Inhibitor-Related Myositis Overlapping With Myocarditis: An Institutional Case Series and a Systematic Review of Literature.
Nakagomi Y; Tajiri K; Shimada S; Li S; Inoue K; Murakata Y; Murata M; Sakai S; Sato K; Ieda M
Front Pharmacol; 2022; 13():884776. PubMed ID: 35645839
[No Abstract] [Full Text] [Related]
7. Immune checkpoint inhibitor-associated myocarditis : Case reports and a review of the literature.
Osinga TE; Oosting SF; van der Meer P; de Boer RA; Kuenen BC; Rutgers A; Bergmann L; Oude Munnink TH; Jalving M; van Kruchten M
Neth Heart J; 2022 Jun; 30(6):295-301. PubMed ID: 35061242
[TBL] [Abstract][Full Text] [Related]
8. Immune checkpoint inhibitor-associated myocarditis: a systematic analysis of case reports.
Wang C; Zhao G; Zhang Z; Yang L; Liu S; Li G; Wang H; Huang J; Wang S; Li N
Front Immunol; 2023; 14():1275254. PubMed ID: 37876928
[TBL] [Abstract][Full Text] [Related]
9. Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.
Mahmood SS; Fradley MG; Cohen JV; Nohria A; Reynolds KL; Heinzerling LM; Sullivan RJ; Damrongwatanasuk R; Chen CL; Gupta D; Kirchberger MC; Awadalla M; Hassan MZO; Moslehi JJ; Shah SP; Ganatra S; Thavendiranathan P; Lawrence DP; Groarke JD; Neilan TG
J Am Coll Cardiol; 2018 Apr; 71(16):1755-1764. PubMed ID: 29567210
[TBL] [Abstract][Full Text] [Related]
10. Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis.
Power JR; Alexandre J; Choudhary A; Ozbay B; Hayek SS; Asnani A; Tamura Y; Aras M; Cautela J; Thuny F; Gilstrap L; Arangalage D; Ewer S; Huang S; Deswal A; Palaskas NL; Finke D; Lehmann LH; Ederhy S; Moslehi J; Salem JE;
Arch Cardiovasc Dis; 2022 May; 115(5):315-330. PubMed ID: 35595646
[TBL] [Abstract][Full Text] [Related]
11. Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment.
Wang C; Lin J; Wang Y; Hsi DH; Chen J; Liu T; Zhou Y; Ren Z; Zeng Z; Cheng L; Ge J
Front Pharmacol; 2021; 12():770631. PubMed ID: 34938185
[No Abstract] [Full Text] [Related]
12. Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases.
Matzen E; Bartels LE; Løgstrup B; Horskær S; Stilling C; Donskov F
Cardiooncology; 2021 Aug; 7(1):27. PubMed ID: 34365980
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy.
Palaskas NL; Segura A; Lelenwa L; Siddiqui BA; Subudhi SK; Lopez-Mattei J; Durand JB; Deswal A; Zhao B; Maximilian Buja L; Iliescu C
Eur J Heart Fail; 2021 Oct; 23(10):1725-1735. PubMed ID: 34114291
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of immune checkpoint inhibitor-associated myocarditis in a single center in China.
Wang F; Sun X; Qin S; Hua H; Liu X; Yang L; Yang M
Chin Clin Oncol; 2020 Apr; 9(2):16. PubMed ID: 32279526
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review of Myocarditis Induced by Immune Checkpoint Inhibitors: How Concerning Is the Most Common Cardiotoxicity of Immune Checkpoint Inhibitors?
Moradi A; Kodali A; Okoye C; Klein DH; Mohamoud I; Olanisa OO; Parab P; Chaudhary P; Mukhtar S; Mohammed L
Cureus; 2023 Jul; 15(7):e42071. PubMed ID: 37602125
[TBL] [Abstract][Full Text] [Related]
16. Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors.
Dolladille C; Ederhy S; Allouche S; Dupas Q; Gervais R; Madelaine J; Sassier M; Plane AF; Comoz F; Cohen AA; Thuny FR; Cautela J; Alexandre J
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31988143
[TBL] [Abstract][Full Text] [Related]
17. Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis.
Vasbinder A; Chen Y; Procureur A; Gradone A; Azam TU; Perry D; Shadid H; Anderson E; Catalan T; Blakely P; Nelapudi N; Fardous M; Bretagne MC; Adie SK; Pogue KT; Leja M; Yentz S; Schneider B; Fecher LA; Lao CD; Salem JE; Hayek SS
JACC CardioOncol; 2022 Dec; 4(5):689-700. PubMed ID: 36636441
[TBL] [Abstract][Full Text] [Related]
18. Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature.
Agrawal N; Khunger A; Vachhani P; Colvin TA; Hattoum A; Spangenthal E; Curtis AB; Dy GK; Ernstoff MS; Puzanov I
Case Rep Oncol; 2019; 12(1):260-276. PubMed ID: 31011325
[TBL] [Abstract][Full Text] [Related]
19. Treatment strategy for myocarditis in patients using immune checkpoint inhibitors or combined anti-vascular endothelial growth factor therapy by clinical severity.
Liu Q; Yu Y; Lin J; Wang Y; Ai L; Li Q; Wu W; Jin H; Li S; Liu M; Yu S; Liu T
Eur J Cancer; 2021 Nov; 157():10-20. PubMed ID: 34464781
[TBL] [Abstract][Full Text] [Related]
20. Prospective screening for myocarditis in cancer patients treated with immune checkpoint inhibitors.
Furukawa A; Tamura Y; Taniguchi H; Kawamura A; Nagase S; Hayashi A; Tada Y; Sase K; Hatake K
J Cardiol; 2023 Jan; 81(1):63-67. PubMed ID: 35953399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
